About us header labcoats.jpg
About Us Thumbnail 08.03.jpg

About Us

BBI Solutions – serving the science of diagnostics 

BBI Solutions has been serving the global diagnostics industry for over 50 years and is the world’s largest independent producer of immuno-diagnostics reagents.   

Our core competencies include a comprehensive suite of reagents with custom development options, lateral flow development, diagnostic manufacturing services and smartphone reader technologies. Leveraging our decades of experience in all stages of diagnostic development for the right solutions the first time. 

Your partner from concept to commercialisation 



Our connected core competencies and end-to-end services mean that you can partner with one company from initial concept of your assay, through development, sourcing reagents, manufacture and commercialisation of your test. 

  • We develop and manufacture critical components for the diagnostics industry and apply our expertise by delivering solutions that bring critical components together in developing and manufacturing point of care and conventional tests.   
  • BBI Solutions’ NovarumTM Mobile Diagnostic Platform complements  the diagnostics workflow to allow rapid interpretation and sharing of assay results. This makes BBI unique among In-vitro diagnostic suppliers.    
  • Our range of immuno-diagnostics reagents includes human antigens, antibodies, gold nanoparticles and conjugates, enzymes, and serum and plasma products.   
  • With manufacturing sites spanning four continents, we produce world-renowned labels for lateral flow, ELISA assay and biosensors, including our high-quality gold nanoparticles and glucose oxidase.   
  • The acquisition of German-based DIARECT AG in June 2020 established BBI as the leading provider of antigens in the autoimmune and tick-borne IVD markets.    

BBI Solutions is part of the BBI Group.  

For more information on our comprehensive range of products and services, please see below.  

Our Reagents products: 

Our Services offering: 

Our Digital service offering: 

To enquire about a particular product or speak to our dedicated customer services team please click here

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox